Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 700-867-1 | CAS number: -
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Genetic toxicity: in vitro
Administrative data
- Endpoint:
- in vitro gene mutation study in bacteria
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- From 2001-10-24 to 2001-11-01
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 2 002
- Report date:
- 2002
Materials and methods
Test guidelineopen allclose all
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 471 (Bacterial Reverse Mutation Assay)
- Deviations:
- no
- Qualifier:
- according to guideline
- Guideline:
- EU Method B.13/14 (Mutagenicity - Reverse Mutation Test Using Bacteria)
- Deviations:
- no
- GLP compliance:
- yes (incl. QA statement)
- Remarks:
- Certificate from the Federal Republic of Germany
- Type of assay:
- bacterial reverse mutation assay
Test material
- Reference substance name:
- rel-(4aR,8aR)-1-bromo-3-methoxy-4a,5,9,10,11,12-hexahydro-6H-[1]benzofuro[3a,3,2-ef][2]benzazepin-6-one hydrochloride (1:1)
- EC Number:
- 700-867-1
- Molecular formula:
- C16H16BrNO3.HCl
- IUPAC Name:
- rel-(4aR,8aR)-1-bromo-3-methoxy-4a,5,9,10,11,12-hexahydro-6H-[1]benzofuro[3a,3,2-ef][2]benzazepin-6-one hydrochloride (1:1)
- Test material form:
- solid
- Details on test material:
- - Name of test material (as cited in study reports): T002102
- Physical state: solid
- Appearance: white (SDS)
Constituent 1
Method
- Target gene:
- histidine locus and tryptophan locus
Species / strain
- Species / strain / cell type:
- other: S. typhimurium TA98, TA100, TA1535, TA1537, and E. coli WP2 uvrA
- Metabolic activation:
- with and without
- Metabolic activation system:
- Phenobarbital and B-naphthoflavone induced rat liver S9
- Test concentrations with justification for top dose:
- Pre-experiment: concentration ranged from 3 to 5000 µg/plate
Experiments I & II: 33, 100, 333, 1000, 2500, and 5000 µg/plate - Vehicle / solvent:
- - Vehicle(s)/solvent(s) used: DMSO
- Justification for choice of solvent/vehicle: The solvent was chosen because of its solubility properties and its relative non-toxicity to the bacteria.
Controlsopen allclose all
- Untreated negative controls:
- yes
- Negative solvent / vehicle controls:
- yes
- True negative controls:
- no
- Positive controls:
- yes
- Positive control substance:
- sodium azide
- Remarks:
- without S9; at 10 μg/plate with TA1535 and TA100
- Untreated negative controls:
- yes
- Negative solvent / vehicle controls:
- yes
- True negative controls:
- no
- Positive controls:
- yes
- Positive control substance:
- other: 4-nitro-ophenylene-diamine
- Remarks:
- without S9; at 10 µg/plate with TA98, 50 µg/plate with TA1537
- Untreated negative controls:
- yes
- Negative solvent / vehicle controls:
- yes
- True negative controls:
- no
- Positive controls:
- yes
- Positive control substance:
- methylmethanesulfonate
- Remarks:
- without S9; at 5 µg/plate with WP2uvrA
- Untreated negative controls:
- yes
- Negative solvent / vehicle controls:
- yes
- True negative controls:
- no
- Positive controls:
- yes
- Positive control substance:
- other: 2-aminoanthracene (2-AA)
- Remarks:
- with S9; at 2.5 μg/plate with TA 1535, TA 1537, TA 98 and TA 100, at 10 μg/plate with WP2 uvrA
- Details on test system and experimental conditions:
- METHOD OF APPLICATION:
in agar (plate incorporation) (experiment I) and preincubation (experiment II)
Experimental performance:
The following materials were mixed in a test tube and poured onto the minmal agar plates:
- 100 µL of test solution at each dose level, solvent (negative control) or reference mutagen solution (positive control)
- 500 µL of S9 mix (for test with metabolic activation) or S9 mix substitution buffer (for test without metabolic activation)
- 100 µL of bacteria suspension (c.f. test system, pre-culture of the strains)
- 2000 µL overlay agar
In the pre-incubation assay 100 µL test solution, 500 µL S9 mix / S9 mix substitution buffer and 100 µL bacterial suspension were mixed in a test tube and shaken at 37°C for 60 minutes. After pre-incubation 2.0 mL overlay agar (45°C) was added to each tube. The mixture was poured on minimal agar plates.
After solidification the plates were incubated upside down for at least 48 h at 37°C in the dark.
DURATION
- Preincubation period: 60 minutes (experiment II)
- Exposure duration: at least 48 hours
- Selection time: 48h (simultaneous with exposure)
SELECTION AGENT: tryptophan (E. coli) and histidine (S. typhimurium)
NUMBER OF REPLICATIONS: triplicates
DETERMINATION OF CYTOTOXICITY
Method:reduction in the number of spontaneous revertants or a clearing of the bacteria background lawn. - Evaluation criteria:
- A test substance is considered positive if a dose related increase in the number of revertants exceeding the threshold or twice the colony count of the corresponding solvent control is observed at more than one concentration. Furthermore, a biologically relevant and reproducible increase exceeding the threshold at one test concentration is considered as positive.
A test substance producing neither a dose-related increase in the number of revertants nor a biologically relevant positive response at any one of the test points is considered non-mutagenic in this system.
A biologically relevant response is described as follows:
An increase is considered relevant if in strains TA98, TA100, and WP2 uvrA the number of reversions is at least twice as high and in strains TA1535 and TA1537 at least three times higher as compared to the spontaneous reversion rate.
Also, a dose-dependent and reproducible increase in the number or revertants is regarded as an indication of possible existing mutagenic potential of the test substance regardless whether the highest dose will induce the above described enhancement factors or not. - Statistics:
- No statistical evaluation was performed.
Results and discussion
Test results
- Species / strain:
- other: S. typhimurium TA98, TA100, TA1535, TA1537, and E. coli WP2 uvrA
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- cytotoxicity
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- valid
- Positive controls validity:
- valid
- Additional information on results:
- TEST-SPECIFIC CONFOUNDING FACTORS
- Effects of pH: no data
- Effects of osmolality: no data
- Evaporation from medium: no data
- Water solubility: no data
- Precipitation: No precipitation of the test substance occurred up to the highest investigated dose.
- Other confounding effects: no data
RANGE-FINDING/SCREENING STUDIES:
To evaluate the toxicity of the test substance a pre-experiment was performed with all the strains. Eight concentrations (3-5000 µg/plate) were tested for toxicity and mutation induction with three plates each. This pre-experiment was reported as part of Experiment I based on the following criteria being met: evaluable plates (>0 colonies) at five concentrations or more in all strains used. This pre-experiment was used to select dose levels for Experiment II.
COMPARISON WITH HISTORICAL CONTROL DATA:
The vehicle and negative control values were within historical data control ranges in the absence of metabolic activation. No data was given for historical ranges in the presence of metabolic activation.
The historical range of positive controls was exceeded without metabolic activation in strains TA1535, TA100 and WP2 uvrA. This effect indicates the sensitivity of the strains rather than compromising the assay. The positive controls showed a distinct increase of induced revertant colonies. Appropriate mutagens were used as positive controls. They showed a distinct increase of induced revertant colonies.
ADDITIONAL INFORMATION ON CYTOTOXICITY:
The plates incubated with the test substance showed normal background growth up to 5000 ug/plate with and without S9 in both experiments. Toxic effects, evident as a reduction in the number of revertants (below the factor of 0.5) were observed at the follow concentrations:
In experiment I, toxic effects were observed at 5000 µg/plate with and without S9 in TA1535 and TA1537, with S9 in TA98, and without S9 in WP2 uvrA.
In experiment II, toxic effects were observed at 333-5000 ug/plate without S9 in TA1535, 2500-5000 µg/plate with S9 in TA1535, 2500-5000 µg/plate without S9 in TA1537, 5000 µg/plate with and without S9 in TA98, 5000 µg/plate without S9 in TA100, 2500-5000 µg/plate without S9 in WP2 uvrA and 5000 µg/plate with S9 in WP2 uvrA. - Remarks on result:
- other: all strains/cell types tested
Applicant's summary and conclusion
- Conclusions:
- Interpretation of results:
negative with metabolic activation
negative without metabolic activation
During the described mutagenicity test and under the experimental conditions reported, the test substance did not induce gene mutation by base pair changes or frameshifts in the genome of the strains used in the Ames test in the presence or absence of metabolic activation. Based on these results, the test substance is not to be classified as mutagenic.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.